F11S (p.Phe11Ser) variant of CMA1 (Chymase)
F11S (p.Phe11Ser) in CMA1 (Chymase) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; high impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.19 / 1. The record also includes structural context.
F11S (p.Phe11Ser) variant details
- p.Phe11Ser
- NCI-TCGA TCGA novel
- Variant assessed as somatic; high impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.189
- ESM-1b 0.00
- AlphaMissense 0.18
- SIFT 0.08
- UniProt: Variant assessed as somatic; high impact.
- Structural context available